Heterologous expression of tylosin polyketide synthase and production of a hybrid bioactive macrolide in Streptomyces venezuelae by Jung, Won Seok et al.
Appl Microbiol Biotechnol
DOI 10.1007/s00253-006-0318-5
APPLIED GENETICS AND MOLECULAR BIOTECHNOLOGY
Won Seok Jung . Sang Kil Lee . Jay Sung Joong Hong .
Sung Ryeol Park . Soon Jeong Jeong . Ah Reum Han .
Jae Kyung Sohng . Byung Gee Kim . Cha Yong Choi .
David H. Sherman . Yeo Joon Yoon
Heterologous expression of tylosin polyketide synthase
and production of a hybrid bioactive macrolide
in Streptomyces venezuelae
Received: 4 November 2005 / Revised: 21 December 2005 / Accepted: 27 December 2005
# Springer-Verlag 2006
Abstract Tylosin polyketide synthase (Tyl PKS) was
heterologously expressed in an engineered strain of
Streptomyces venezuelae bearing a deletion of pikromycin
PKS gene cluster using two compatible low-copy plasmids,
each under the control of a pikAI promoter. The mutant
strain produced 0.5 mg/l of the 16-membered ring
macrolactone, tylactone, after a 4-day culture, which is a
considerably reduced culture period to reach the maximum
production level compared to other Streptomyces hosts. To
improve the production level of tylactone, several
precursors for ethylmalonyl-CoA were fed to the growing
medium, leading to a 2.8-fold improvement (1.4 mg/ml);
however, switching the pikAI promoter to an actI promoter
had no observable effect. In addition, a small amount of
desosamine-glycosylated tylactone was detected from the
extract of the mutant strain, revealing that the native
glycosyltransferase DesVII displayed relaxed substrate
specificity in accepting the 16-membered ring macrolac-
tone to produce the glycosylated tylactone. These results
demonstrate a successful attempt for a heterologous
expression of Tyl PKS in S. venezuelae and introduce S.
venezuelae as a rapid heterologous expression system for
the production of secondary metabolites.
Introduction
Polyketides are useful natural products that include im-
portant therapeutic agents, such as antibacterial, immuno-
suppressive, and cholesterol-lowering compounds (O’Hagan
1991). The number of cloned and sequenced genes involved
in polyketide biosynthesis has increased rapidly during the
past decade, and increasing knowledge on genetic informa-
tion has enabled the manipulation of polyketide biosynthetic
pathways to yield novel compounds. However, many of the
original polyketide producers are difficult to manipulate
genetically, have poor growth characteristics, or yield poor
titers. The transfer of biosynthetic genes from the original
producers to a more amenable and robust heterologous host
therefore becomes an attractive alternative to producing high
levels of desired compounds or to providing a basis for
subsequent combinatorial biosynthetic approaches (Pfeifer
and Khosla 2001; Rude and Khosla 2004; Wenzel and
Muller 2005). The most widely used heterologous hosts
for polyketide production are Streptomyces coelicolor
(McDaniel et al. 1995) and Streptomyces lividans
(Ziermann and Betlach 1999). In these strains, a number
of metabolic pathways have been successfully engineered
to increase the titer of natural products themselves and to
generate a variety of novel unnatural products. Sacchar-
opolyspora erythraea (Gaisser et al. 2000; Martin et al.
2003) and Streptomyces fradiae (Rodriguez et al. 2004;
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Reeves et al. 2004) have been also engineered to create
strains that could be used for the production of novel
polyketides through heterologous expression and manipu-
lation of polyketide biosynthetic pathways. However, these
heterologous hosts have a slow growth rate and need
relatively prolonged culture periods (6–9 days) to reach the
maximum production level of metabolites in the fermenta-
tion process. In contrast, Streptomyces venezuelae has been
recently developed as a heterologous host (Yoon et al. 2002;
Jung et al. 2003; Hong et al. 2004) that requires a short
culture period (3–4 days) for metabolite production
compared to other Streptomyces species (Xue and Sherman
2001). It is also amenable to genetic manipulation and has
high transformation efficiency. These characteristics make
S. venezuelae an alternative system for a rapid heterologous
production of polyketides from benchtop genetic manipu-
lation to product fermentation (Xue and Sherman 2001).
Tylosin polyketide synthase (Tyl PKS) encoded by
tylGI–V of S. fradiae is responsible for the biosynthesis of
the macrolactone, tylactone, which is further modified by
oxidation at C-20 and C-23 and glycosylation of mycami-
nose, mycinose, and mycarose to produce tylosin (Fig. 1a).
Tyl PKS has a biochemical architecture similar to that of the
pikromycin (Pik) PKS of S. venezuelae (Fig. 1b). Based on
this similarity between Tyl PKS and Pik PKS, the hybrid
Tyl–Pik modular PKS system in S. venezuelae has been
developed in a previous study (Yoon et al. 2002). The
expression of several hybrid PKS resulted in the production
of macrolactones with predicted structural alterations and
further elaborated structures by the action of post-PKS-
modifying enzymes of S. venezuelae, DesVII glycosyl-
transferase, and PikC hydroxylase.
In this study, we describe the expression of the entire Tyl
PKS from two compatible plasmids in a Pik-PKS-deleted
strain of S. venezuelae in order to probe the applicability of
S. venezuelae as a heterologous host for the expression of a
whole PKS gene cluster. The resulting strain produced a
16-membered ring macrolactone, tylactone, in a consider-
ably reduced culture period (4 days) compared to those of
other Streptomyces heterologous hosts. Interestingly,
tylactone was further modified probably by the action of
flexible glycosyltransferase DesVII, leading to its deso-
samine-glycosylated derivative. Furthermore, the produc-
tion level of tylactone was enhanced considerably through
the feeding of several precursors of ethylmalonyl-CoA,
which is expected to be the limiting substrate of Tyl PKS
in S. venezuelae. This work demonstrates the unique
capacity of S. venezuelae as a new system for the rapid
expression of heterologous PKS and the creation of hybrid
polyketides.
Materials and methods
Bacterial strains, culture conditions,
and genetic manipulation
S. venezuelaeATCC15439 was used for the construction of
mutant strains. The transformants of S. venezuelae were
selected on R2YE agar plates (Kieser et al. 2000) by
overlaying with an appropriate antibiotic or a combination
of antibiotics (Yoon et al. 2002). SGGP liquid medium
(Kieser et al. 2000) was used for the propagation of S.
venezuelae. S. fradiae ATCC19609 grown in tryptic soy
broth medium (Kieser et al. 2000) was used for the
preparation of genomic DNA. Genetic manipulation was
performed in Escherichia coli DH10B using standard
protocols (Sambrook et al. 2001). Transformation of DNA
into protoplasts of S. venezuelae followed standard
protocols (Kieser et al. 2000). Litmus28 (New England
Biolabs) and pGEM-3Zf(+) (Promega) were used for
subcloning, and Southern blot hybridization was per-
formed according to the protocol recommended by a
digoxigenin labeling and detection kit (Roche).
Fig. 1 Organization of Tyl PKS
genes and pikromycin biosyn-
thetic gene cluster. a Organiza-
tion of Tyl PKS genes and
structures of tylactone and
tylosin. b Organization of
pikromycin biosynthetic gene
cluster and structures of narbo-
nolide and pikromycin. Each
arrow represents an open read-
ing frame (ORF). The direction
of transcription and the relative
sizes of ORFs are indicated
Construction of pikA deletion mutant
A gene replacement plasmid (pYJ230) derived from
pKC1139 (Bierman et al. 1992), which contains an
apramycin-resistant marker, was constructed for the replace-
ment of pikAI–IV genes by hygromycin resistance gene
(Elhai andWolk 1988). Plasmid pYJ230 was constructed by
cloning the hygromycin resistance gene flanked by two 1-kb
fragments homologous to the upstream and downstream
regions of pikA. The following primers with engineered
restriction sites (underlined) were used to generate the two 1-
kb fragments by polymerase chain reaction (PCR): a
HindIII–XbaI fragment containing the upstream region of
pikAI (forward, 5′-AAAAAGCTTGGGGATGTGGCGCC
GGAGGATCTC-3′; reverse, 5′-TTTTCTAGACATCCGG
CTCCGTCTCCGGAAGCC-3′) and a KpnI–EcoRI frag-
ment containing pikAV and part of desVIII (forward, 5′-
AAAGGTACCGAGGGGGCGGGCAAGTGACCGACAG
AC-3′; reverse, 5′-AAAGAATTCGGACAGCGGCCGG
AGCCGCTCCAG-3′). The plasmid pYJ230 was intro-
duced into a previously constructed pikAIII–IV deletion
mutant of S. venezuelae YJ004 (Yoon et al. 2002), for
plasmid-mediated homologous recombination, as de-
scribed previously (Yoon et al. 2002). Several double
crossover mutants were identified on the basis of their
phenotype of hygromycin resistance and apramycin sensi-
tivity, and their genotype by Southern blot hybridization.
The resulting strain was designated DHS2001.
Expression of Tyl PKS under the control
of pikAI promoter
Tyl PKS genes were individually cloned into two compat-
ible vectors, pDHS702 (Xue and Sherman 2000) and
pDHS618 (Zhao et al. 1999), which are E.coli–Streptomy-
ces shuttle vectors containing a pikAI promoter (Xue and
Sherman 2001), SCP2* origin, and different antibiotic
resistance genes. The tylGI–III genes were cloned into
pDHS702 as a MunI–NsiI fragment by combining an
EcoRI–SphI partial fragment of tylGI–III isolated from
pSET506 (a gift from Eli Lilly Co.; GenBank accession
number SFU78289), a MunI–EcoRI fragment of the 5′
region, and an SphI–NsiI fragment of the 3′ region of
tylGI–III genes amplified by PCR to generate pBB155
(Fig. 1a). Both ends of tylGI–III were obtained by PCR
using the following primers: a MunI–EcoRI fragment
containing the 5′ end of tylGI (forward, 5′-AAACAATT
GACACAGCTCGGTGACACGGCAGCC-3′; reverse, 5′-
AAAGAATTCCTCGACACCGGCCGCGCCCGGCAG-3′)
and an SphI–NsiI fragment containing the 3′ end of tylGIII
(forward, 5′- AAAGCATGCAACGGCGCCTGAACCG
GAGCGGCA-3′; reverse, 5'-AAAATGCATGTGTTTTCAC
CTGTGCTGTCGCTG-3′) (restriction sites are underlined).
The plasmid pDHS3003 (Fig. 2b) expressing tylGIV–V
under the control of the pikAI promoter was constructed as
described previously (Yoon et al. 2002). Transformation of
the DHS2001 strain by the plasmids pBB155 and
pDHS3003 generated the mutant strain YJ005.
Expression of Tyl PKS expression under the control
of actI promoter
An actI promoter and a pathway-specific activator gene
(actII–ORF4) (McDaniel et al. 1993) were also used for the
expression of Tyl PKS. A 1.43-kb PacI–KpnI fragment
containing an actI/actII–ORF4 promoter–activator pair was
amplified from pHGF7505 (Yu et al. 2001) by PCR and
ligated to a 313-bp KpnI–EcoRI fragment corresponding to
the 5′ end of tylGI amplified by PCR from the genomic
DNA of S. fradiae. The resulting PacI–EcoRI fragment was
ligated to the same sites of pBB155 to generate pYJ153.
The following primers with engineered restriction sites
(underlined) were used: a PacI–KpnI fragment (forward, 5′-
AAGCTTTTAATTAAAGTTTAAACAGCTCGGATT-3′; re-
verse, 5′-ATCCTTGGTACCTCGATGCGTTCGTCCGGT
GGT-3′) and a KpnI–EcoRI fragment (forward, 5′-GCCG
CAGGTACCGTTGGCAGGCTCACCGGCACG-3′; re-
verse, 5′-TTCCCAGAATTCCTCGACACCGGCCGCGC
CCGG-3). The EcoRI–XbaI fragment containing tylGIV–V
genes from plasmid pDHS3003 was transferred to the same
sites of a pRM5 derivative (McDaniel et al. 1993), which
contains the actI/actII–ORF4 promoter–activator pair and
apramycin resistance gene. The resulting plasmid was
designated pYJ154.
Production and analysis of heterologous polyketides
All strains were cultured on R2YE solid medium (Kieser et
al. 2000) at 30°C for 4 days with appropriate antibiotic
selection. Agar medium production gives more reproduc-
ible results than liquid fermentation, although liquid
fermentation typically supports the same level of antibiotic
production. Agar-grown culture was diced and extracted
with 2 vol of methanol. The extract was washed with water,
extracted again with 1 vol of chloroform, and concentrated
with methanol. The extract was analyzed for polyketide
production on a reverse-phase C18 column (4.6×250 mm
Watchers 120 ODS-BP, 5 μm; Daiso Watchers) with a
binary mobile phase (solvent A: acetonitrile/methanol=4:1
with 5 mM ammonium acetate; solvent B: 5 mM ammo-
nium acetate in H2O; A: 20–75%, 30 min; 75%, 10 min;
75–20%, 10 min) at a flow rate of 1 ml/min (Rodriguez et
al. 2004) by the combination of liquid chromatography/
mass spectrometry (LC/MS) and mass spectrometry/mass
Fig. 2 Maps of plasmids for the expression of Tyl PKS. a An
expression plasmid pBB155 containing tylGI–III. b An expression
plasmid pDHS3003 containing tylGIV–V
spectrometry (MS/MS) using a Finnigan LCQ-DecaXP
with an electrospray source. A purified tylactone standard
(kindly provided by Professor Eric Cundliffe at University
of Leicester) was used to generate a calibration curve for
titer determination. The production level of tylactone was
averaged from five separate cultivations and extractions.
Results
Generation of Pik PKS deletion mutant
of S. venezuelae DHS2001
A strain for the expression of heterologous PKS
(DHS2001) was constructed by deleting the native Pik
PKS from the chromosome of S. venezuelae and by
replacing with the hygromycin resistance gene through a
plasmid-mediated homologous recombination. A pikAV
gene encoding a type II thioesterase desosamine (des)
biosynthetic gene cluster, a pikC gene encoding a cyto-
chrome P450 hydroxylase, and a pikD gene encoding a
pathway-specific activator (Xue et al. 1998a,b; Wilson et
al. 2001) downstream of Pik PKS (Fig. 1b) remain intact in
DHS2001. The genomic DNA of the resulting mutant
strain was analyzed by Southern blot hybridization to
confirm double crossover (data not shown). The culture
extract of strain DHS2001 was analyzed, and no antibiotic
production was observed. Feeding the pikromycin agly-
cone, narbonolide, to the growing medium of DHS2001
restored the production of pikromycin, which is synthe-
sized through the attachment of desosamine to narbonolide
at C-5 oxygen by DesVII glycosyltransferase and by the
addition of a hydroxyl group at C-12 position by PikC
hydroxylase (Fig. 1b). This result indicates that the
remaining des cluster, the monooxygenase pikC, and the
pathway-specific activator pikD genes are functional in
DHS2001.
Heterologous expression of the entire Tyl PKS
in S. venezuelae DHS2001
A previous study revealed that two SCP2*-derived
plasmids carrying different antibiotic markers were com-
patible and stable during growth (Xue et al. 1999). For the
expression of the entire Tyl PKS, two plasmids containing
SCP2* replication origin and two different resistance genes
were used. The expression plasmids pBB155 (carrying
tylGI–III; Fig. 2a) and pDHS3003 (carrying tylGIV–V;
Fig. 2b) were constructed and transformed into the pikA
deletion mutant DHS2001. Transformants resistant to
apramycin and thiostrepton were isolated and designated
YJ005. The organic extract of YJ005 was analyzed by LC/
MS and MS/MS for identification of tylactone. A major
peak was observed at a retention time of 30.7 min with m/
z=395 and 377, consistent with the calculated molecular
weight for tylactone and its dehydrated form, respectively,
from LC/MS analysis (Fig. 3a). MS/MS fragmentation of
this compound with m/z=395 produced a pattern identical
to the characteristic fragmentation pattern of a tylactone
standard (data not shown), thus confirming the presence of
tylactone in the growing medium of YJ005. In addition, a
peak with m/z=552 was observed at a retention time of
43.0 min from LC/MS analysis (Fig. 3a), corresponding to
desosaminyl tylactone, which is known to be a biologically
active compound against the majority of Gram-positive
bacteria (Furumai et al. 1977). The compound with m/
z=552 fragmented into peaks at m/z=534, 395, 377, and
158, corresponding to the dehydrated form of desosaminyl
tylactone, tylactone, dehydrated form of tylactone, and
Fig. 3 LC/MS and MS/MS analyses of compounds from the extract
of YJ005. a A major peak was observed at a retention time of
30.7 min with m/z=395 and 377, consistent with the calculated
molecular weight for tylactone and its dehydrated form, respectively.
A minor peak was detected at 43.0 min with m/z=552, which
corresponds to desosaminyl tylactone. b The compound with m/
z=552 fragmented into peaks at m/z=158, 377, 395, and 534,
corresponding to characteristic desosamine moiety ion (oxonium
ion), a dehydrated form of tylactone, tylactone, and a dehydrated
form of desosaminyl tylactone, respectively
oxonium ion fragment derived from desosamine (Butler et
al. 2002), respectively (Fig. 3b). This fragmentation pattern
is consistent with the previous report in which 5-O-
desosaminyl tylactone was synthesized by feeding tylactone
to a mutant of Sa. erythraea that is deficient in eryA-
encoding erythromycin PKS and both eryCIII and eryBV
glycosyltransferases but containing the tylosin tylMII
glycosyltransferase gene (Gaisser et al. 2000). The yield
of tylactone in S. venezuelae YJ005 was approximately
0.5 mg/l, and the percentage conversion of tylactone into
desosaminyl tylactone was approximately 8.3% based on
the peak intensity from LC/MS analysis. The maximum
level of tylactone production was reached after a 4-day
culture (Fig. 4).
Feeding several precursors for ethylmalonyl-CoA
to the culture medium of YJ005
Besides malonyl-CoA and methylmalonyl-CoA, the bio-
synthesis of tylactone requires ethylmalonyl-CoA as an
extender unit, which is incorporated into the tylosin
polyketide backbone by an ethylmalonyl-specific acyl-
transferase in module 5 of Tyl PKS. However, Pik PKS
does not require ethylmalonyl-CoA as an extender unit for
the biosynthesis of pikromycin. Successful production of
tylactone in S. venezuelae suggests that this strain certainly
contains the biosynthetic pathway for ethylmalonyl-CoA.
However, it is uncertain whether S. venezuelae contains a
sufficient pool of intracellular ethylmalonyl-CoA to sup-
port the efficient biosynthesis of tylactone. To address this
question, S. venezuelae YJ005 was grown on R2YE medi-
um containing precursors for ethylmalonyl-CoA, such as
butanol, butyrate, and diethylmalonate (Stassi et al. 1998).
Consequently, supplementation with the precursors for
ethylmalonyl-CoA into the growing medium resulted in
enhancement of tylactone productivity. When 50 mM
butanol, 50 mM butyrate, and 10 mM diethylmalonate
were added to the growing medium during inoculation, the
production of tylactone increased by about 1.4-fold
(0.7 mg/l), 1.6-fold (0.8 mg/l), and 2.8-fold (1.4 mg/l),
respectively.
Tyl PKS expression under the control of actI promoter
The actI promoter and its cognate activator gene actII–
ORF4 from the actinorhodin biosynthetic gene cluster of S.
coelicolor (McDaniel et al. 1993) have been widely used to
express several large PKS genes in genetically engineered
“clean” host strains of S. coelicolor and S. lividans (Pfeifer
and Khosla 2001). Erythromycin PKS was expressed under
the control of the actI promoter after integration into the
chromosome by homologous recombination in a mutant
strain of Sa. erythraea that is deficient in native PKS, and
the resulting strain produced a high quantity of erythro-
mycin when compared with the wild-type Sa. erythraea
(Rowe et al. 1998). In contrast, use of this promoter–
activator in a Sa. erythraea overproducer resulted in a >20-
fold decrease in erythromycin titers compared to the strain
using a native eryAI promoter. (Rodriguez et al. 2003). To
investigate the effect of promoters on the productivity of
heterologous polyketide in S. venezuelae, the actI promoter
and the actII–ORF4 activator gene were tested to express
Tyl PKS in the S. venezuelae mutant strain. The plasmids
containing Tyl PKS under the control of the actI promoter
were constructed and introduced into the pikA deletion
mutant DHS2001 to generate YJ048. The organic extract
of YJ048 was analyzed by LC/MS and MS/MS. The
calculated molecular weights corresponding to tylactone
and desosaminyl tylactone were detected. The amount of
tylactone produced from YJ048 was similar to levels
produced from the YJ005 strain, demonstrating that
substitution of the pikAI promoter with the actI promoter
did not affect the production level of heterologous
polyketides in this host–vector system.
Discussion
S. venezuelae is a suitable heterologous host for the
expression of polyketide biosynthetic genes due to its a fast
growth, which allows large quantities of cell mass and
metabolites to be harvested relatively quickly compared to
other Streptomyces species (Xue and Sherman 2001).
Development of the genetically engineered strain of S.
venezuelae DHS2001 and rapid production of tylactone in
the mutant strain validated the unique advantage of S.
venezuelae as an attractive host for the production of
heterologous polyketides. In addition, biosynthetic path-
ways for the three most common precursors found in
modular polyketide biosynthesis (malonyl-CoA, methyl-
malonyl-CoA, and ethylmalonyl-CoA) seem to be present
in S. venezuelae as proven by the production of tylactone
from the YJ005 strain, which requires all of the three
common precursors. The presence of a range of precursors
for the biosynthesis of polyketides in S. venezuelae would
facilitate the heterologous expression of a diverse class of
PKS.
The flexibility of DesVII glycosyltransferase in accept-
ing new sugar donors as substrate has been demonstrated
from previous reports (Zhao et al. 1998a,b, 2001; Yamase
et al. 2000; Borisova et al. 1999; Hong et al. 2004). DesVII
Fig. 4 Production level of tylactone on R2YE solid medium from
YJ005. S. venezuelae YJ005 was cultured on R2YE solid medium
up to 5 days at 30°C
has also been shown to be flexible toward hybrid
aglycones, to which the sugar is attached (Yoon et al.
2002). The unique property of DesVII has allowed
researchers to explore the possibility of generating novel
macrolide derivatives attached with new sugars. The
current study takes this a step further by showing that
DesVII, which normally accepts both 12- and 14-
membered ring macrolactones, is capable of accepting a
16-membered ring, tylactone, as an aglycone substrate. The
successful generation of desosaminyl tylactone has further
expanded the usefulness of glycosyltransferases as a tool
for the generation of new hybrid polyketide structures. In
another study, a pikromycin producer (Streptomyces sp. no.
4,900, in which the activity of the KS domain of PKS was
inhibited by cerulenin) also successfully converted tylac-
tone (200 mg) into 5-O-desosaminyl tylactone (30 mg)
with a 15% conversion yield (Omura et al. 1980), which is
approximately 2-fold higher than that of S. venezuelae
(DesVII). The glycosyltransferase of another pikromycin
producer Streptomyces sp. no. 4,900 seems to have a higher
efficiency in converting tylactone to desosaminyl tylactone
than DesVII, and its catalytic efficiency toward unnatural
substrates would be worth investigating further.
Although the glycosylation site of tylactone was not
determined due to this low conversion yield, it is likely that
desosamine was introduced to the oxygen at position C-5
of tylactone, according to the intrinsic catalytic specificity
of DesVII. Further analysis, such as by nuclear magnetic
resonance spectroscopy, is required to confirm the glyco-
sylation site of tylactone. No hydroxylated forms of
tylactone and desosaminyl tylactone were detected,
although the monooxygenase PikC of S. venezuelae was
known to have considerably relaxed substrate specificity
(Yoon et al. 2002; Lee et al. 2005) toward alternative
substrates, indicating that tylactone and desosaminyl
tylactone may be poor substrates for PikC.
The level of production of tylactone in S. venezuelae is
relatively low and requires further improvement. In this
study, two simple strategies were employed to enhance the
production level of tylactone. First, the limiting precursor
was added to the growing medium. Ethylmalonyl-CoA,
which is required for the biosynthesis of tylactone, was
expected to be limiting in the S. venezuelae system since
pikromycin production in wild type does not require
ethylmalonyl-CoA as a precursor. Supplementation with
several precursors for ethylmalonyl-CoA, such as butanol,
butyrate, or diethylmalonate, into the growing medium led
to improvement in tylactone production, suggesting that
ethylmalonyl-CoA may be a limiting factor for the
biosynthesis of tylactone in S. venezuelae. Second, Tyl
PKS was expressed under the control of the actI promoter.
Similar levels of tylactone production were observed when
Tyl PKS was expressed under the control of either an actI
promoter or a pikAI promoter. Switching promoters had no
observable effect, although expression levels of Tyl PKS
may have been different in using the actI promoter or the
pikAI promoter. Taken together, the major factor limiting
the production level of tylactone seems to be deficiency in
the intracellular pool of ethylmalonyl-CoA rather than the
expression level of PKS in this system. Previous work
revealed that Tyl PKS genes have an independent expres-
sion pattern in which tylGI and tylGIII–V are under
differential regulation in S. fradiae (Stratigopoulos and
Cundliffe 2002). According to this observation, tylGIII
expression in pBB155 and pYJ153 could be expressed
independently under the control of its intrinsic promoter in
S. venezuelae, which would be another explanation for the
fact that switching the pikA promoter by actI/actII–ORF4
had no observable effect on tylactone production.
The newly developed S. venezuelae system described in
this study has both promising and limiting factors as a
heterologous host. The limiting factor is the relatively low
production yield of heterologous polyketides compared to
other well-developed Streptomyces host. Features of S.
venezuelae, including rapid growth rate and quick produc-
tion of metabolites, are favorable characteristics for
heterologous polyketide production that cannot be easily
endowed by genetic engineering. Reducing the time for
bacteria culture has important implications for the produc-
tion of metabolites through the fermentation process; thus,
this unique advantage of S. venezuelae as a fast-growing
bacteria (doubling time, approximately 1 h) is an attractive
feature in developing a heterologous host. Further works
on enhancing the production level of heterologous
polyketides through metabolite engineering strategies will
facilitate the development of S. venezuelae as a competent
heterologous host.
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